Skip to main content
OpenTrials
Completed

NCT Number: NCT00701844

Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Leukemia Acute Leukemia Acute Lymphocytic Leukemia Anemia Anemia, Aplastic Blood Protein Disorders Bone Marrow Diseases Bone Marrow Failure Disorders Cardiovascular Diseases Hematologic Diseases Hematological Cancers Hemic and Lymphatic Diseases Hemorrhagic Disorders Hemostatic Disorders Immune System Diseases Immunoproliferative Disorders Leukemia, Lymphoid Lymphatic Diseases Lymphoma Lymphoproliferative Disorders Multiple Myeloma Neoplasms Neoplasms by Histologic Type Neoplasms, Plasma Cell Paraproteinemias Precursor Cell Lymphoblastic Leukemia-Lymphoma Psychological Distress Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hackensack University Medical Center, Hackensack, New Jersey, United States

Loading trial locations.

About this study

This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed
  • Be at least 18 years old now (and at least 16 when they had their transplant)
  • Speak English
  • Have telephone service

Exclusion criteria

  • None

Treatment and study plan

Writing A (Experimental informative writing)

Behavioral

Experimental informative writing

Writing B (Experimental noninformative writing)

Behavioral

Experimental noninformative writing

Writing C (Control informative writing)

Behavioral

Control informative writing

Writing D (Control noninformative writing)

Behavioral

Control noninformative writing

Primary outcomes

  1. Psychological Adjustment

    Time frame: At screening, baseline and 3 months following intervention

Secondary outcomes

  1. Quality of Life

    Time frame: At screening, baseline and 3 months following intervention

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • American Cancer Society, Inc.

Registry information

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Jun 19, 2008
Registry last updated
Nov 17, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.